02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
As described in our previous article, the Dubai International Financial Centre (DIFC) is in the proc...
Read More >
As readers of this blog know, three separate groups have filed lawsuits seeking to block or overturn...
Read More >
The USDOL is busy again issuing Opinion Letters and has again turned its focus to the issue of inclu...
Read More >
Among the many rule changes recently announced by the National Labor Relations Board (NLRB) was one ...
Read More >
With great power comes great responsibility. Certainly this is true of employer-employee relationshi...
Read More >
It’s been far too long since our last installment from March 2019, but my ongoing dialogue with Nin...
Read More >